[PERSON]
Mike Doustdar
Featured in 2 tracked stories · first seen
Situations
GLP‑1 obesity drug rollout and market
93 clusters · 449 sources · last updated
Latest: Novo Nordisk lifts outlook despite Wegovy oral miss and CagriSema setback
In early May 2026 Novo Nordisk’s share price began to recover after a March low, helped by a partnership with Hims & Hers to sell Wegovy. June saw France announce 65 % reimbursement for Wegovy and Mounjaro, widening Euro